Atlas Trials

LEA29Y (Belatacept) Emory Edmonton Protocol

Clinical trial NCT00468403 · COMPLETED

Trial details

NCT number
NCT00468403
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2008-10-01
Primary completion
2012-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.